INVO Bioscience, Inc. (INVO)
USD 0.83
(-2.0%)
USD 0.83
(-2.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 264.5 Thousand USD | 0.34% |
| 2022 | 263.6 Thousand USD | -8.4% |
| 2021 | 287.77 Thousand USD | 8.44% |
| 2020 | 265.37 Thousand USD | 161.74% |
| 2019 | 101.38 Thousand USD | 133.0% |
| 2018 | 43.51 Thousand USD | -26.1% |
| 2017 | 58.87 Thousand USD | -30.9% |
| 2016 | 85.21 Thousand USD | 30.25% |
| 2015 | 65.42 Thousand USD | 4.75% |
| 2014 | 62.45 Thousand USD | -4.75% |
| 2013 | 65.57 Thousand USD | 21.71% |
| 2012 | 53.87 Thousand USD | -9.48% |
| 2011 | 59.51 Thousand USD | -14.08% |
| 2010 | 69.27 Thousand USD | 9.72% |
| 2009 | 63.13 Thousand USD | -10.73% |
| 2008 | 70.72 Thousand USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 250.06 Thousand USD | -6.15% |
| 2024 Q1 | 266.45 Thousand USD | 0.74% |
| 2023 FY | 264.5 Thousand USD | 0.34% |
| 2023 Q3 | 254.22 Thousand USD | -9.21% |
| 2023 Q4 | 264.5 Thousand USD | 4.05% |
| 2023 Q2 | 280.01 Thousand USD | 3.36% |
| 2023 Q1 | 270.91 Thousand USD | 2.78% |
| 2022 Q3 | 280.13 Thousand USD | -0.66% |
| 2022 Q4 | 263.6 Thousand USD | -5.9% |
| 2022 FY | 263.6 Thousand USD | -8.4% |
| 2022 Q1 | 294.63 Thousand USD | 2.38% |
| 2022 Q2 | 281.99 Thousand USD | -4.29% |
| 2021 Q1 | 268.34 Thousand USD | 1.12% |
| 2021 Q2 | 250.78 Thousand USD | -6.55% |
| 2021 FY | 287.77 Thousand USD | 8.44% |
| 2021 Q4 | 287.77 Thousand USD | -0.9% |
| 2021 Q3 | 290.39 Thousand USD | 15.79% |
| 2020 Q1 | 162.28 Thousand USD | 60.06% |
| 2020 FY | 265.37 Thousand USD | 161.74% |
| 2020 Q3 | 241.48 Thousand USD | -1.07% |
| 2020 Q2 | 244.1 Thousand USD | 50.42% |
| 2020 Q4 | 265.37 Thousand USD | 9.89% |
| 2019 Q2 | 76.47 Thousand USD | 47.96% |
| 2019 Q3 | 69.33 Thousand USD | -9.34% |
| 2019 FY | 101.38 Thousand USD | 133.0% |
| 2019 Q4 | 101.38 Thousand USD | 46.24% |
| 2019 Q1 | 51.68 Thousand USD | 18.78% |
| 2018 Q1 | 54.94 Thousand USD | -6.69% |
| 2018 FY | 43.51 Thousand USD | -26.1% |
| 2018 Q4 | 43.51 Thousand USD | -2.44% |
| 2018 Q3 | 44.6 Thousand USD | -24.91% |
| 2018 Q2 | 59.4 Thousand USD | 8.12% |
| 2017 Q1 | 79.49 Thousand USD | -6.71% |
| 2017 Q3 | 63.43 Thousand USD | -9.62% |
| 2017 Q2 | 70.19 Thousand USD | -11.7% |
| 2017 Q4 | 58.87 Thousand USD | -7.19% |
| 2017 FY | 58.87 Thousand USD | -30.9% |
| 2016 FY | 85.21 Thousand USD | 30.25% |
| 2016 Q3 | 85.46 Thousand USD | -2.61% |
| 2016 Q1 | 62.96 Thousand USD | -3.76% |
| 2016 Q2 | 87.75 Thousand USD | 39.38% |
| 2016 Q4 | 85.21 Thousand USD | -0.3% |
| 2015 FY | 65.42 Thousand USD | 4.75% |
| 2015 Q4 | 65.42 Thousand USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2014 FY | 62.45 Thousand USD | -4.75% |
| 2013 FY | 65.57 Thousand USD | 21.71% |
| 2012 FY | 53.87 Thousand USD | -9.48% |
| 2011 Q3 | 59.85 Thousand USD | -2.96% |
| 2011 Q1 | 65.03 Thousand USD | -6.12% |
| 2011 Q4 | 59.51 Thousand USD | -0.56% |
| 2011 Q2 | 61.68 Thousand USD | -5.15% |
| 2011 FY | 59.51 Thousand USD | -14.08% |
| 2010 Q4 | 69.27 Thousand USD | 21.33% |
| 2010 Q3 | 57.09 Thousand USD | 3.26% |
| 2010 Q2 | 55.29 Thousand USD | -3.9% |
| 2010 Q1 | 57.53 Thousand USD | -8.86% |
| 2010 FY | 69.27 Thousand USD | 9.72% |
| 2009 FY | 63.13 Thousand USD | -10.73% |
| 2009 Q4 | 63.13 Thousand USD | -5.13% |
| 2009 Q1 | 74.74 Thousand USD | 5.69% |
| 2009 Q3 | 66.54 Thousand USD | -2.88% |
| 2009 Q2 | 68.51 Thousand USD | -8.34% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q4 | 70.72 Thousand USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 FY | 70.72 Thousand USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 3.31 Million USD | 92.009% |
| BrainsWay Ltd. | 3.71 Million USD | 92.884% |
| Cerus Corporation | 39.86 Million USD | 99.337% |
| Envoy Medical, Inc. | 1.4 Million USD | 81.16% |
| electroCore, Inc. | 2.16 Million USD | 87.754% |
| Helius Medical Technologies, Inc. | 457 Thousand USD | 42.121% |
| IceCure Medical Ltd | 2.27 Million USD | 88.373% |
| Inogen, Inc. | 21.84 Million USD | 98.789% |
| OrthoPediatrics Corp. | 105.85 Million USD | 99.75% |
| Lucid Diagnostics Inc. | 278 Thousand USD | 4.854% |
| Monogram Orthopaedics, Inc. | 1.00 USD | -26450600.0% |
| MaxCyte, Inc. | 12.22 Million USD | 97.837% |
| NeuroOne Medical Technologies Corporation | 1.72 Million USD | 84.681% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -69.1% |
| Orthofix Medical Inc. | 222.16 Million USD | 99.881% |
| PAVmed Inc | 1.01 Million USD | 73.991% |
| Rapid Micro Biosystems, Inc. | 19.96 Million USD | 98.675% |
| RxSight, Inc. | 17.42 Million USD | 98.482% |
| Sight Sciences, Inc. | 7.84 Million USD | 96.63% |
| SI-BONE, Inc. | 20.24 Million USD | 98.694% |
| TELA Bio, Inc. | 13.16 Million USD | 97.99% |
| Treace Medical Concepts, Inc. | 29.24 Million USD | 99.096% |
| Vivos Therapeutics, Inc. | 1.00 USD | -26450600.0% |
| Acutus Medical, Inc. | 4.27 Million USD | 93.817% |
| Talis Biomedical Corporation | - USD | -Infinity% |
| Spectral AI, Inc. | 230 Thousand USD | -15.003% |
| Nano-X Imaging Ltd. | 2.35 Million USD | 88.773% |
| CVRx, Inc. | 10.98 Million USD | 97.592% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 390.07 Thousand USD | 32.191% |
| Bioventus Inc. | 91.33 Million USD | 99.71% |
| Venus Concept Inc. | 28.67 Million USD | 99.078% |
| TriSalus Life Sciences, Inc. | 2.54 Million USD | 89.607% |
| LivaNova PLC | 147.88 Million USD | 99.821% |
| 908 Devices Inc. | 14.93 Million USD | 98.229% |
| Alphatec Holdings, Inc. | 136.84 Million USD | 99.807% |
| Nemaura Medical Inc. | 1.75 Million USD | 84.927% |
| NeuroPace, Inc. | 11.21 Million USD | 97.641% |
| LENSAR, Inc. | 15.68 Million USD | 98.314% |
| Apyx Medical Corporation | 9.92 Million USD | 97.334% |
| Cutera, Inc. | 72.1 Million USD | 99.633% |
| STRATA Skin Sciences, Inc. | 2.67 Million USD | 90.104% |
| BioSig Technologies, Inc. | -103 Thousand USD | 356.803% |
| Anika Therapeutics, Inc. | 46.38 Million USD | 99.43% |
| ClearPoint Neuro, Inc. | 7.91 Million USD | 96.656% |
| Integra LifeSciences Holdings Corporation | 389.6 Million USD | 99.932% |
| Axonics, Inc. | 79.94 Million USD | 99.669% |
| Outset Medical, Inc. | 49.21 Million USD | 99.463% |
| IRIDEX Corporation | 9.9 Million USD | 97.33% |
| PROCEPT BioRobotics Corporation | 39.75 Million USD | 99.335% |
| IRadimed Corporation | 12.82 Million USD | 97.937% |
| Tivic Health Systems, Inc. | 756 Thousand USD | 65.012% |
| Telesis Bio, Inc. | 4.02 Million USD | 93.428% |
| Viemed Healthcare, Inc. | 4.6 Million USD | 94.255% |
| Varex Imaging Corporation | 277.5 Million USD | 99.905% |
| Quipt Home Medical Corp. | 18.32 Million USD | 98.557% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 16.74 Million USD | 98.42% |
| Dynatronics Corporation | 5.59 Million USD | 95.272% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 3.74 Million USD | 92.93% |
| Semler Scientific, Inc. | 445 Thousand USD | 40.56% |
| InMode Ltd. | 45.09 Million USD | 99.413% |
| Bruker Corporation | 968.3 Million USD | 99.973% |
| Cytosorbents Corporation | 3.68 Million USD | 92.813% |
| DexCom, Inc. | 559.6 Million USD | 99.953% |
| Align Technology, Inc. | 296.9 Million USD | 99.911% |
| Viveve Medical, Inc. | 1.47 Million USD | 82.031% |
| ZimVie Inc. | 79.6 Million USD | 99.668% |
| Movano Inc. | 1.51 Million USD | 82.518% |
| Cytek Biosciences, Inc. | 60.87 Million USD | 99.566% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -69.1% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 157.93 Million USD | 99.833% |
| Profound Medical Corp. | 6.95 Million USD | 96.196% |
| Insulet Corporation | 402.6 Million USD | 99.934% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 14.83 Million USD | 98.217% |
| iCAD, Inc. | 917 Thousand USD | 71.155% |
| Nuwellis, Inc. | 1.99 Million USD | 86.755% |
| Biotricity, Inc. | 1.87 Million USD | 85.926% |
| iRhythm Technologies, Inc. | 13.97 Million USD | 98.107% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 2.1 Million USD | 87.44% |
| PAVmed Inc. | 1.01 Million USD | 73.991% |
| BIOLASE, Inc. | 11.43 Million USD | 97.686% |
| Beyond Air, Inc. | 2.12 Million USD | 87.564% |
| FONAR Corporation | 2.71 Million USD | 90.259% |
| AxoGen, Inc. | 23.02 Million USD | 98.851% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 22.52 Million USD | 98.826% |
| Inari Medical, Inc. | 42.9 Million USD | 99.383% |
| UFP Technologies, Inc. | 70.19 Million USD | 99.623% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 629.17 Thousand USD | 57.96% |
| Tenon Medical, Inc. | 554 Thousand USD | 52.255% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 1.66 Million USD | 84.111% |
| AdaptHealth Corp. | 113.64 Million USD | 99.767% |
| Sintx Technologies, Inc. | 888 Thousand USD | 70.213% |
| NanoVibronix, Inc. | 2.73 Million USD | 90.318% |
| Quanterix Corporation | 22.36 Million USD | 98.817% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 14.84 Million USD | 98.218% |
| Pacific Biosciences of California, Inc. | 56.67 Million USD | 99.533% |
| TransMedics Group, Inc. | 44.23 Million USD | 99.402% |
| ReWalk Robotics Ltd. | 5.65 Million USD | 95.321% |
| NeuroMetrix, Inc. | 1.55 Million USD | 83.038% |
| Hyperfine, Inc. | 6.58 Million USD | 95.981% |
| Establishment Labs Holdings Inc. | 79.93 Million USD | 99.669% |
| Biomerica, Inc. | 2.37 Million USD | 88.868% |
| Bone Biologics Corporation | -328.84 Thousand USD | 180.435% |
| AVITA Medical, Inc. | 3.12 Million USD | 91.526% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 29.87 Million USD | 99.115% |